Recent advances in the development of celecoxib analogs as anticancer agents: A review
Sign Up to like & getrecommendations! Published in 2022 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.202200326
Abstract: Celecoxib is a nonsteroidal anti‐inflammatory drug (NSAID) designed to be a selective cyclooxygenase‐2 (COX‐2) inhibitor. It was approved by the U.S. Food and Drug Administration for the treatment of inflammatory diseases such as osteoarthritis and… read more here.
Keywords: advances development; development celecoxib; recent advances; activity ... See more keywords